| Name | Title | Contact Details |
|---|
Pivot is a leading behavioral change digital health company aiming to engage employers and health plans who are eager to deliver elevated wellness solutions to individuals. Pivot Breathe, our flagship product, empowers millions to reduce and quit all forms of tobacco - and we`re just getting started.
Prior to Upward Health, Ward served as the Senior Vice President of Analytics at CareSource, a large health plan based in Ohio with multiple product lines in several states. Before CareSource, Ward held data and analytics leadership roles at a wide range of healthcare companies including Navvis, Corizon Health, naviHealth, and Centene. Ward brings to Upward Health a deep experience building prediction models, implementing business intelligence solutions, and driving process improvement through technology innovation.
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI`s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
Genia Photonics Inc. is a Lasalle, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.